# Semaglutide FAQ: Straight Answers, Cited

> Semaglutide FAQ: is it good for the heart, how does it work, side effects, half-life, oral vs injection, and semaglutide vs tirzepatide — direct answers, cited.

## Is semaglutide good for the heart?

The evidence says yes for specific groups. In SELECT (17,604 adults with heart disease and obesity, no diabetes), semaglutide 2.4 mg cut major adverse cardiovascular events by 20% (HR 0.80; 95% CI 0.72-0.90) [3]. In type 2 diabetes at high cardiovascular risk, SUSTAIN-6 showed a 26% reduction (HR 0.74) [2]. Both are cardiovascular outcome trials, the strongest kind of evidence for a heart claim.

## Does semaglutide reduce the risk of heart attack and stroke?

Yes, in the trial populations studied. The composite endpoint in both SELECT and SUSTAIN-6 included nonfatal heart attack and nonfatal stroke alongside cardiovascular death. SELECT lowered that composite by 20% in people with heart disease and obesity (HR 0.80) [3]; SUSTAIN-6 lowered it by 26% in high-risk type 2 diabetes (HR 0.74; 95% CI 0.58-0.95) [2].

## What were the results of the SELECT cardiovascular trial?

SELECT randomized 17,604 adults with established cardiovascular disease and a BMI of 27 or higher, none with diabetes, to once-weekly semaglutide 2.4 mg or placebo. The primary composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke fell by 20% (HR 0.80; 95% CI 0.72-0.90; P<0.001) [3]. A 2024 analysis confirmed the benefit across weight and glycemia subgroups [13].

## What is semaglutide?

Semaglutide is a 31-amino-acid peptide engineered as a long-acting analogue of the gut hormone GLP-1, in the GLP-1 receptor agonist drug class [12]. It is FDA-approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction in people with heart disease and obesity, and (2025) a serious fatty-liver disease. In STEP 1 it produced a mean 14.9% weight loss at 68 weeks versus 2.4% with placebo [1].

## What is semaglutide used for?

It is FDA-approved for several uses: type 2 diabetes, long-term weight management, reducing major adverse cardiovascular events in adults with established cardiovascular disease and overweight or obesity, and (2025) metabolic dysfunction-associated steatohepatitis (MASH) [12]. The cardiovascular indication rests on SELECT's 20% reduction in major cardiovascular events [3]; the weight indication on STEP 1's 14.9% mean loss [1].

## How does semaglutide work?

It activates the GLP-1 receptor — the same one the natural gut hormone uses — to boost glucose-dependent insulin release, suppress glucagon, slow the stomach, and reach brain appetite circuits [12]. In rodents it lowered weight through central nervous system pathways (brainstem, area postrema, hypothalamic arcuate and parabrachial nuclei), reducing food intake without lowering energy expenditure [4].

## How does semaglutide work for weight loss?

Mainly by reducing how much people eat, not by burning more energy. In rodents it accessed brain appetite centers, cut food intake, and shifted food preference with no fall in energy expenditure [4]. Clinically, STEP 1 produced a mean body-weight change of -14.9% versus -2.4% with placebo at 68 weeks [1].

## What is the semaglutide dosage for weight loss?

The documented chronic-weight-management schedule escalates the once-weekly subcutaneous dose from 0.25 mg to a 2.4 mg maintenance dose over about four months, the dose used in STEP 1 [12][1]. This is the schedule documented in trials and labeling, reported here as fact, not as advice for any individual.

## How many mg is 40 units of semaglutide?

There is no reliable public unit-to-milligram conversion for semaglutide, and "units" is not how the approved pens are dosed — they deliver fixed milligram doses (for example, the 2.4 mg weight-management dose) [12]. Volume-based "unit" measuring is associated with compounded products, where the FDA has documented dosing errors and unverified ingredients [5]. This site does not provide dose conversions.

## What is compounded semaglutide?

Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than the approved manufactured product. It was permitted during a declared shortage; the FDA documented dosing errors, hospitalizations, and products with unverified or non-pharmaceutical active ingredients [5]. The pathway was curtailed after the shortage was declared resolved in 2025 [12], and it sits outside the trial evidence base.

## What are the side effects of semaglutide?

The dominant side effects are gastrointestinal — nausea (roughly one-third of patients), vomiting, diarrhea, and constipation — mostly mild-to-moderate and transient, concentrated during dose escalation [5]. Biliary disease is increased, and diabetic-retinopathy complications rose in SUSTAIN-6 with rapid glucose correction (HR 1.76) [5][2]. The full breakdown is on [the effects page](/effects).

## How long does it take for semaglutide to work?

Effects build gradually as the dose escalates over weeks to months. STEP 1 measured its mean 14.9% weight loss at week 68, with weight falling steadily across that period rather than all at once [1]. Blood-sugar effects in diabetes trials likewise accrue over weeks. There is no single "it kicks in at day X" figure in the trials.

## How long does semaglutide stay in your system?

A long time, by drug standards. The elimination half-life is approximately one week, so meaningful drug levels persist for about five weeks after the last dose [12]. That durability comes from strong albumin binding and DPP-4 resistance built into the molecule [12], and it is why a multi-week washout is advised before a planned pregnancy [17].

## What is the half-life of semaglutide?

Approximately one week — commonly cited as about 165-168 hours — for both the subcutaneous and oral formulations, with effectively complete clearance roughly five weeks after the final dose [12]. The long half-life is conferred by reversible albumin binding via the C18 fatty di-acid side chain plus DPP-4 resistance from the Aib-8 substitution [12].

## Is oral semaglutide as effective as the injection?

For cardiovascular safety in diabetes, oral semaglutide was noninferior to placebo for major adverse cardiovascular events in PIONEER 6, with numerically lower death rates [8]. Direct oral-versus-injection efficacy depends on the dose and indication, and the tablet's very low bioavailability (~0.4-1%) makes correct fasted administration essential to its effect [12].

## How long does it take for semaglutide to suppress appetite?

Appetite effects are reported early but build with dose escalation. Mechanistically, semaglutide acts on brain appetite circuits — the brainstem, area postrema, and hypothalamic arcuate nucleus — to reduce food intake [4]. The trials measured weight outcomes over weeks rather than timing the first appetite change, so there is no precise clinical "hours to appetite suppression" figure.

## Why am I not losing weight on semaglutide?

Response varies between people, and this site cannot give individual guidance. What the trials show is an average: STEP 1's mean was -14.9% at 68 weeks, but it was a mean — individual results spread around it, and weight loss often slows after the early period [1]. Stopping the medication is followed by substantial regain [19]. Questions about personal results belong with a prescriber.

## Does semaglutide make you tired?

Fatigue is a commonly reported community complaint, especially in the first day or two after an injection and during early weeks, usually easing with time — but it is anecdotal, not a controlled-trial finding [3]. In the trials the dominant adverse effects were gastrointestinal rather than fatigue [5]. The labeled community reports are collected on [the effects page](/effects).

## Is semaglutide a GLP-1?

Yes — semaglutide is a GLP-1 receptor agonist, a long-acting analogue of the natural gut hormone glucagon-like peptide-1, sharing about 94% of its sequence [12]. It belongs to the incretin-mimetic drug class and works by activating the GLP-1 receptor on the pancreas, gut, and brain [12].

## Does semaglutide cause hair loss?

Hair shedding appears as a pharmacovigilance signal, but the leading explanation is telogen effluvium — reversible diffuse shedding triggered by the rate and magnitude of weight loss — rather than a direct drug effect [15][16]. A disproportionality analysis flagged the alopecia signal for semaglutide and tirzepatide; a dermatology study tied the shedding to weight-loss speed [15][16].

## How fast does semaglutide work?

Gradually, by design — the dose is escalated over weeks specifically to limit gastrointestinal effects [5]. STEP 1 measured its mean 14.9% weight loss at week 68, with the change accumulating over that window [1]. There is no validated trial figure for a rapid onset; the medication is built around slow titration and a week-long half-life [12].

## What is the difference between semaglutide and tirzepatide?

They are different molecules with different receptor targets, and there is now a head-to-head. In SURMOUNT-5 (751 adults with obesity), tirzepatide produced greater mean weight loss than semaglutide at 72 weeks (-20.2% vs -13.7%; P<0.001) [21]. On hard cardiovascular outcomes, semaglutide is the agent with the large dedicated event trial (SELECT, 20% MACE reduction) behind it [3].

---

A plain-spoken audit of the semaglutide trial record with the cardiovascular outcomes read first and the hype read last — an editorial digest, not a clinic, a prescriber, or a vendor.